1. Home
  2. HUIZ vs KTTA Comparison

HUIZ vs KTTA Comparison

Compare HUIZ & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huize Holding Limited

HUIZ

Huize Holding Limited

HOLD

Current Price

$1.69

Market Cap

16.8M

Sector

Finance

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.51

Market Cap

18.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HUIZ
KTTA
Founded
2006
2020
Country
China
United States
Employees
N/A
5
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.8M
18.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
HUIZ
KTTA
Price
$1.69
$0.51
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$2.30
$3.00
AVG Volume (30 Days)
6.3K
312.7K
Earning Date
06-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$8.58
N/A
Revenue Next Year
$6.64
N/A
P/E Ratio
$7.81
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.04
$0.28
52 Week High
$4.16
$2.06

Technical Indicators

Market Signals
Indicator
HUIZ
KTTA
Relative Strength Index (RSI) 48.74 37.76
Support Level $1.19 $0.42
Resistance Level $1.35 $0.52
Average True Range (ATR) 0.06 0.04
MACD 0.00 0.00
Stochastic Oscillator 41.35 21.94

Price Performance

Historical Comparison
HUIZ
KTTA

About HUIZ Huize Holding Limited

Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies that cooperate with the company, which the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers a digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.

Share on Social Networks: